The Results: Breaking Down 28.7% Weight Loss Primary Efficacy Outcomes Both retatrutide doses met all primary and key secondary endpoints with statistical and clinical significance: The 12mg dose achieved the highest weight loss on record for a Phase 3 obesity trial, with more than 1 in 4 pounds lost from baseline body weight
Doing so would be the only way to definitively prove efficacy and safety
You can estimate youre going to increase your production by 10%, said Mike Ganio, senior director of pharmacy practice and quality with the American Society of Health-System Pharmacists, but is that going to be enough? Meanwhile, conditions that could feed future shortages still exist
Allegra L, Sasso MD, Bovio C, et al
In DKD kidney biopsy samples, long-chain acylcarnitines correlate with renal tubular lipotoxicity, mitochondrial dysfunction, and cell death
At standard therapeutic doses, tirzepatide generally produces greater weight loss than semaglutide in head-to-head comparisons